Trial
NCT03419403
UNITE Study: Understanding New Interventions With GBM ThErapy
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
AbbVie
Collaborators
—
Condition
Glioblastoma Multiforme
Intervention
Steroid eye drops
Why stopped
The study was terminated because clinical development of depatuxizumab mafodotin in glioblastoma was stopped due to lack of survival benefit.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-14